Data as of November 12, 2026
Amlodipine-Valsartan-Hydrochlorothiazide 10-160-25 mg Tab
AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE
Brand: AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE
Acquisition price (NADAC) is as of October 21, 2026. Medicaid reimbursement figures are from 2024, the most recent year in CMS's published claims data. The two are not contemporaneous — treat any comparison as directional, not exact.
Price per fill
NADAC (acquisition)
$310.41/ fill$6.11 / EA
Cost Plus Drugs (retail)
$238.00/ fill$4.69 / EA
FUL
$544.99/ fill$10.73 / EA
AMP
$311.43/ fill$6.13 / EA
Medicaid FFS
$415.18/ fill
Medicaid MCO
$326.23/ fill
Sources: cms/nadac:price-ladder · costplusdrugs/price-list · cms/ful:generic-ceiling · cms/sdud. Cost Plus prices as of 2026-11-12
What's in the reimbursement
Ingredient cost (50.8 units/fill)$310.41
Dispensing fee & other (state-fixed, not margin)$104.77
Total reimbursed per fill$415.18
The gap above stays roughly flat across drugs regardless of acquisition cost — that's the professional dispensing fee, a fixed per-fill amount the state pays every pharmacy, not a markup.
Medicaid volume backing this card: 2 fee-for-service states, 4 managed-care states.
Full methodology and source columns: /tools/drug-prices/methodology